Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 93

1.

Fusions between dendritic cells and whole tumor cells as anticancer vaccines.

Koido S, Homma S, Okamoto M, Namiki Y, Takakura K, Uchiyama K, Kajihara M, Arihiro S, Imazu H, Arakawa H, Kan S, Komita H, Ito M, Ohkusa T, Gong J, Tajiri H.

Oncoimmunology. 2013 May 1;2(5):e24437.

2.

Dendritic-Tumor Fusion Cell-Based Cancer Vaccines.

Koido S.

Int J Mol Sci. 2016 May 26;17(6). pii: E828. doi: 10.3390/ijms17060828. Review.

3.

Cancer vaccine by fusions of dendritic and cancer cells.

Koido S, Hara E, Homma S, Namiki Y, Ohkusa T, Gong J, Tajiri H.

Clin Dev Immunol. 2009;2009:657369. doi: 10.1155/2009/657369. Epub 2010 Feb 18. Review.

4.

Dendritic-tumor fusion cells in cancer immunotherapy.

Takakura K, Kajihara M, Ito Z, Ohkusa T, Gong J, Koido S.

Discov Med. 2015 Mar;19(104):169-74.

5.

Dendritic/tumor fusion cell-based vaccination against cancer.

Koido S, Hara E, Homma S, Fujise K, Gong J, Tajiri H.

Arch Immunol Ther Exp (Warsz). 2007 Sep-Oct;55(5):281-7. Review.

PMID:
18219758
6.

Strategies to improve the immunogenicity of anticancer vaccines based on dendritic cell/malignant cell fusions.

Koido S, Homma S, Okamoto M, Namiki Y, Takakura K, Uchiyama K, Kajihara M, Arihiro S, Imazu H, Arakawa H, Kan S, Komita H, Kamata Y, Ito M, Ohkusa T, Gong J, Tajiri H.

Oncoimmunology. 2013 Sep 1;2(9):e25994. Epub 2013 Sep 12. Review.

7.

The impact of dendritic cell-tumor fusion cells on cancer vaccines - past progress and future strategies.

Kajihara M, Takakura K, Ohkusa T, Koido S.

Immunotherapy. 2015;7(10):1111-22. doi: 10.2217/imt.15.73. Epub 2015 Oct 28. Review.

PMID:
26507578
8.

Dendritic cell-tumor fusion vaccines for renal cell carcinoma.

Avigan D.

Clin Cancer Res. 2004 Sep 15;10(18 Pt 2):6347S-52S. Review.

9.

Dendritic cell fusion vaccines for cancer immunotherapy.

Rosenblatt J, Kufe D, Avigan D.

Expert Opin Biol Ther. 2005 May;5(5):703-15. Review.

PMID:
15934845
10.

Fusions of breast cancer and dendritic cells as a novel cancer vaccine.

Avigan D.

Clin Breast Cancer. 2003 Feb;3 Suppl 4:S158-63. Review.

PMID:
12620154
11.

Strategies for antigen choice and priming of dendritic cells influence the polarization and efficacy of antitumor T-cell responses in dendritic cell-based cancer vaccination.

Galea-Lauri J, Wells JW, Darling D, Harrison P, Farzaneh F.

Cancer Immunol Immunother. 2004 Nov;53(11):963-77. Epub 2004 May 14.

PMID:
15146294
12.

Regulation of tumor immunity by tumor/dendritic cell fusions.

Koido S, Homma S, Hara E, Namiki Y, Takahara A, Komita H, Nagasaki E, Ito M, Ohkusa T, Gong J, Tajiri H.

Clin Dev Immunol. 2010;2010:516768. doi: 10.1155/2010/516768. Epub 2010 Oct 26. Review.

13.

Dendritic cell-tumor fusion vaccine prevents tumor growth in vivo.

Kim GY, Chae HJ, Kim KH, Yoon MS, Lee KS, Lee CM, Moon DO, Lee JS, Jeong YI, Choi YH, Park YM.

Biosci Biotechnol Biochem. 2007 Jan;71(1):215-21. Epub 2007 Jan 7.

15.

Local secretion of IL-12 augments the therapeutic impact of dendritic cell-tumor cell fusion vaccination.

Tan C, Dannull J, Nair SK, Ding E, Tyler DS, Pruitt SK, Lee WT.

J Surg Res. 2013 Dec;185(2):904-11. doi: 10.1016/j.jss.2013.06.045. Epub 2013 Jul 17.

PMID:
23891424
16.

Antigen-specific polyclonal cytotoxic T lymphocytes induced by fusions of dendritic cells and tumor cells.

Koido S, Homma S, Hara E, Namiki Y, Ohkusa T, Gong J, Tajiri H.

J Biomed Biotechnol. 2010;2010:752381. doi: 10.1155/2010/752381. Epub 2010 Apr 7.

17.
18.

Cell fusion between dendritic cells and whole tumor cells.

Koido S, Gong J.

Methods Mol Biol. 2015;1313:185-91. doi: 10.1007/978-1-4939-2703-6_13.

PMID:
25947665
19.

Dendritic-tumor cell hybrids induce tumor-specific immune responses more effectively than the simple mixture of dendritic and tumor cells.

Pinho MP, Sundarasetty BS, Bergami-Santos PC, Steponavicius-Cruz K, Ferreira AK, Stripecke R, Barbuto JA.

Cytotherapy. 2016 Apr;18(4):570-80. doi: 10.1016/j.jcyt.2016.01.005.

PMID:
26971685
20.

Dendritic/tumor fusion cells as cancer vaccines.

Avigan D, Rosenblatt J, Kufe D.

Semin Oncol. 2012 Jun;39(3):287-95. doi: 10.1053/j.seminoncol.2012.02.003. Review.

PMID:
22595051

Supplemental Content

Support Center